Lv1
70 积分 2025-06-25 加入
Trends in the landscape of clinical trials of innovative drugs in China since 2015
7小时前
待确认
Antibody-drug conjugate design and mechanisms of action for cancer treatment: state of the art and beyond
1个月前
已完结
Trastuzumab deruxtecan in hormone receptor–positive, HER2-low/-ultralow metastatic breast cancer (DESTINY-Breast06): outcome analyses by time to progression on prior first-line endocrine therapy with CDK4/6 inhibitor and baseline burden of disease
2个月前
已完结
Adjuvant Epirubicin Plus Cyclophosphamide Followed by Taxanes With or Without Carboplatin in Early-Stage Triple-Negative Breast Cancer (RJBC 1501): A Randomized Phase III Trial
4个月前
已完结
In vivo CAR engineering for immunotherapy
5个月前
已完结
Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery
5个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
5个月前
已完结
20 years since the approval of first EGFR-TKI, gefitinib: Insight and foresight
7个月前
已完结
50 years of Progress in Non-Small Cell Lung Cancer: A New Fellow’s Guide in the Clinic
7个月前
已完结
Understanding the impact of psychosocial working conditions on workers’ health: we have come a long way, but are we there yet?
7个月前
已完结
皖公网安备34019202002308
